The questionnaire seeks views on whether the claimed public benefits are sufficient to outweigh the competition concerns that have twice derailed the transaction.
The expanded offering comes as regulators and corporates across Asia-Pacific show growing interest in captives and other alternative risk-transfer mechanisms.
The deal values the Australian retirement income business at approximately A$7.94bn (US$5.53bn) and follows Dai-ichi Life's proposed acquisition of New Zealand's Fidelity Life.
Falling premiums reflect surplus capital rather than lower exposure, PARIMA speakers said, as geopolitical, AI, climate and labour risks combine and compound.
Malaysia’s RHB says talks on selling its insurance arm have made “meaningful progress”, but the parties still need to finalise the transaction terms and documents.
Panellists at PARIMA’s Singapore conference said captives are drawing more interest as fewer risks suit standard cover, but setting one up is hard without the actuaries, claims experts and insurers to...